A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

NCT03193190 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Nab-Paclitaxel
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Fluorouracil
DRUG: Atezolizumab
DRUG: Cobimetinib
DRUG: PEGPH20
DRUG: BL-8040
DRUG: Selicrelumab
DRUG: Bevacizumab
DRUG: RO6874281
DRUG: AB928
DRUG: Tiragolumab
DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche